Neil F. McFarlane

President and CEO, Director, Zevra Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.2M

Companies

Latest trade

Oct 12, 2026

Companies

Zevra Therapeutics, Inc.President and CEO, Director −$1.4M

Trades

ZVRA Sold 20,000 shares at $11.25 · planned $0.2M Oct 12

ZVRA Sold 14,625 shares at $8.56 · planned $0.1M Feb 9

ZVRA Sold 91,000 shares at $9.38 · planned $0.9M Feb 2

ZVRA Sold 19,500 shares at $10.82 · planned $0.2M Oct 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.